These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 17869373)

  • 1. Assessment of low-grade hepatic encephalopathy: a critical analysis.
    Kircheis G; Fleig WE; Görtelmeyer R; Grafe S; Häussinger D
    J Hepatol; 2007 Nov; 47(5):642-50. PubMed ID: 17869373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy.
    Kircheis G; Hilger N; Häussinger D
    Gastroenterology; 2014 Apr; 146(4):961-9. PubMed ID: 24365582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study.
    Amodio P; Campagna F; Olianas S; Iannizzi P; Mapelli D; Penzo M; Angeli P; Gatta A
    J Hepatol; 2008 Sep; 49(3):346-53. PubMed ID: 18602716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy.
    Bajaj JS; Saeian K; Verber MD; Hischke D; Hoffmann RG; Franco J; Varma RR; Rao SM
    Am J Gastroenterol; 2007 Apr; 102(4):754-60. PubMed ID: 17222319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical flicker frequency for quantification of low-grade hepatic encephalopathy.
    Kircheis G; Wettstein M; Timmermann L; Schnitzler A; Häussinger D
    Hepatology; 2002 Feb; 35(2):357-66. PubMed ID: 11826409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy.
    Bajaj JS; Hafeezullah M; Franco J; Varma RR; Hoffmann RG; Knox JF; Hischke D; Hammeke TA; Pinkerton SD; Saeian K
    Gastroenterology; 2008 Nov; 135(5):1591-1600.e1. PubMed ID: 18723018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simplified psychometric evaluation for the diagnosis of minimal hepatic encephalopathy.
    Riggio O; Ridola L; Pasquale C; Pentassuglio I; Nardelli S; Moscucci F; Merli M; Montagnese S; Amodio P; Merkel C
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):613-6.e1. PubMed ID: 21440091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized double blind placebo controlled trial of probiotics in minimal hepatic encephalopathy.
    Saji S; Kumar S; Thomas V
    Trop Gastroenterol; 2011; 32(2):128-32. PubMed ID: 21922877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy.
    Sugimoto R; Iwasa M; Maeda M; Urawa N; Tanaka H; Fujita N; Kobayashi Y; Takeda K; Kaito M; Takei Y
    Am J Gastroenterol; 2008 Jun; 103(6):1413-20. PubMed ID: 18510613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant.
    Mardini H; Saxby BK; Record CO
    Gastroenterology; 2008 Nov; 135(5):1582-90. PubMed ID: 18647604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a three-factor neuropsychological approach for detecting minimal hepatic encephalopathy.
    Stewart CA; Enders FT; Schneider N; Felmlee-Devine D; Kamath PS; Smith GE
    Liver Int; 2010 Jul; 30(6):841-9. PubMed ID: 20412441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the inhibitory control task to detect minimal hepatic encephalopathy.
    Amodio P; Ridola L; Schiff S; Montagnese S; Pasquale C; Nardelli S; Pentassuglio I; Trezza M; Marzano C; Flaiban C; Angeli P; Cona G; Bisiacchi P; Gatta A; Riggio O
    Gastroenterology; 2010 Aug; 139(2):510-8, 518.e1-2. PubMed ID: 20470775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis.
    Quero JC; Hartmann IJ; Meulstee J; Hop WC; Schalm SW
    Hepatology; 1996 Sep; 24(3):556-60. PubMed ID: 8781324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and therapy of portosystemic encephalopathy].
    Weissenborn K
    Schweiz Rundsch Med Prax; 1994 Sep; 83(38):1059-64. PubMed ID: 7939069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis.
    Compañy L; Zapater P; Pérez-Mateo M; Jover R
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):519-25. PubMed ID: 20010298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):27-32. PubMed ID: 20133225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of abnormal psychometric tests and critical flicker frequency after clinical recovery of overt hepatic encephalopathy.
    Sharma P; Sharma BC; Sarin SK
    Neurol India; 2010; 58(2):220-4. PubMed ID: 20508339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis.
    Schmid M; Peck-Radosavljevic M; König F; Mittermaier C; Gangl A; Ferenci P
    Liver Int; 2010 Apr; 30(4):574-82. PubMed ID: 20456040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of bispectral index for classification of overt hepatic encephalopathy: a multicentre, observer blinded, validation study.
    Dahaba AA; Worm HC; Zhu SM; Bao FP; Salah A; Zakaria S; Bornemann H; Stadlbauer V; Rehak PH; Metzler H; Stauber RE
    Gut; 2008 Jan; 57(1):77-83. PubMed ID: 17698861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal hepatic encephalopathy: time to recognise and treat.
    Dhiman RK; Chawla YK
    Trop Gastroenterol; 2008; 29(1):6-12. PubMed ID: 18564660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.